Functional disturbance of the stress-adaptation system in patients with scleroderma

References

• Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481–91.
   PubMed Web of Science ®Google Scholar
• Kuroki T, Ohta A, Aoki Y, Kawasaki S, Sugimoto N, Ootani H, et al. Stress maladjustment in the pathoetiology of ulcerative colitis. J Gastroenterol. 2007;42:522–7.
   PubMed Web of Science ®Google Scholar
• Crofford U. The hypothalamic—pituitary—adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol Metab Clin Noth Am. 2002;31:1–13.
   PubMed Web of Science ®Google Scholar
• Elenkov U, Chrousos GP. Stress system: organization, physiol-ogy and immunoregulation. Neuroimmunomodulation. 2006;13: 257–67.
   PubMed Web of Science ®Google Scholar
• Thomason B, Brantley P, Jones G, Dyer H, Morris J. The relation between stress and disease activity in rheumatoid arthritis. J Behav Med. 1992;15:215–20.
   Google Scholar
• Affleck G, Tennen H, Urrows S, Higgins P. Person and contex-tual features of daily stress reactivity: individual differences in relations of undesirable daily events with mood disturbance and chronic pain intensity. J Pers Soc Psychol. 1994;66:329–40.
   PubMed Web of Science ®Google Scholar
• Potter PT, Zautra AJ. Stressful life events on rheumatoid arthritis disease activity. J Consult Clin Psychol. 1997;65:319–23.
   PubMed Web of Science ®Google Scholar
• Marcenaro M, Prete C, Badini A, Sulli A, Magi E, Cutolo M. Rheumatoid arthritis, personality, stress response style, and coping with illness: a preliminary survey. Ann NY Acad Sci. 1999;876:419–25.
   PubMed Web of Science ®Google Scholar
• Neeck G, Federlin K, Graef V, Rusch D, Schmidt K. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol. 1990;17:24–9.
   Google Scholar
• Chikanza I, Petrou P, Kingsley G, Chrousos G, Panayi G. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 1992;35 :1281–8.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Sano H, Karalis K, Friedman T, Epps H, Remmers E, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol. 1993;151:1587–96.
   PubMed Web of Science ®Google Scholar
• Gudbjomsson B, Skogseid B, Oberg K, Wide L, Hallgren R. Intact adrenocorticotropic hormone secretion but impaired corti-sol response in patients with active rheumatoid arthritis: effect of glucocorticoids. J Rheumatol. 1996;23:596–602.
   Google Scholar
• Masi A, Chrousus G. Hypothalamic-pituitary-adrenal-gluco-corticoid axis function in rheumatoid arthritis. J Rheumatol. 1996;23:577–81.
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 1997;82:1279–83.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol. 1999;26:277–81.
   PubMed Web of Science ®Google Scholar
• Mukai E, Nagashima M, Hirano D, Yoshino S. Comparative study of symptoms and neuroendocrine-immune network medi-ator levels between rheumatoid arthritis patients and healthy subjects. Clin Exp Rheumatol. 2000;18:585–90.
   PubMed Web of Science ®Google Scholar
• Hirano D, Nagashima M, Ogawa R, Yoshino S. Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. J Rheumatol. 2001;28:490–5.
   PubMed Web of Science ®Google Scholar
• Costa D, Dobkin P, Pinard L, Fortin P, Danoff D, Esdaile J, et al. The role of stress in functional disability among women with systemic lupus erythematosus: a prospective study. Arthritis Care Res. 1999;12:112–9.
   PubMed Web of Science ®Google Scholar
• Ward M, Lotstein D, Bush T, Lambert E, Vollenhoven R, Neuwelt C. Psychosocial correlates of morbidity in women with systemic lupus erythematosus. J Rheumatol. 1999;26:2153–8.
   PubMed Web of Science ®Google Scholar
• Harle P, Straub R, Wiest R, Schomerich J, Atzeni F, Carrabba M, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis. 2006;65:51–6.
   PubMed Web of Science ®Google Scholar
• Zietz B, Reber T, Oertel M, Gluck T, Scholmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 2000;27: 911–8.
   Google Scholar
• Gutierrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus. 1998;7:404–8.
   Google Scholar
• Rovensky J, Blazickova S, Rauova D, Koska J, Lukac J, Vigas M. The hypothalamic-pituitary response in SUE. Regulation of prolactin, growth hormone and cortisol release. Lupus. 1998; 7:409–13.
   Google Scholar
• Brown GW, Harris T. Stressor, vulnerability and depression: a question of replication. Psychol Med. 1986;16:739–44.
   PubMed Web of Science ®Google Scholar
• Imrich R, Lukac J, Rovensky J, Radikova Z, Penesova A, Kvetnansky R, et al. Lower adrenocortical and adrenomedullary responses to hypoglycemia in premenopausal women with sys-temic sclerosis. J Rheumatol. 2006;33:2235–41.
   PubMed Web of Science ®Google Scholar
• Subcommittee for Scleroderma Criteria of the American Rheu-matism Association Diagnostic and Therapeutic Criteria Com-mittee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–90.
   PubMed Web of Science ®Google Scholar
• Fujii T, Ogino S, Arimoto H, Irifune M, Iwata N, Ookawachi I, et al. Quality of life in patients with Japanese cedar pollinosis: using the SF-8 health status questionnaire (Japanese version) (in Japanese with English abstract). Arerugi. 2006;55:1288–94.
   PubMedGoogle Scholar
• Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 health survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003;12: 1003–12.
   Google Scholar
• Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum. 1983;26:1346–53.
   Google Scholar
• Iwahashi S, Tanaka Y, Fukudo S, Hongo M. The development of the Japanese version of the perceived stress scale (in Japanese with English abstract). Jpn J Psychosom Med. 2002;42:459–66.
   Google Scholar
• Cohen S, Kamarck T, Mermelstein R. A global measure of per-ceived stress. J Health Soc Behav. 1983;24:385–96.
   PubMed Web of Science ®Google Scholar
• Antonovsky A. The structure and properties of sense of coherence scale. Soc Sic Med. 1993;36:725–33.
   PubMed Web of Science ®Google Scholar
• Callahan LF, Pincus T. The sense of coherence scale in patients with rheumatoid arthritis. Arthritis Care Res. 1995;8:28–35.
   PubMed Web of Science ®Google Scholar
• Togari T, Yamazaki Y. Examination of the reliability and factor validity of 13-item five-point version sense of coherence scale (in Japanese with English abstract). Minzoku Eisei. 2005;71:168–82.
   Google Scholar
• Utsunomiya T, Yoshida K, Nishimura Y, Morooka T, Ohtsubo Y, Tsuji S, et al. Effects of mental stress on blood pressure and heart rate: comparison with exercise stress in normal subjects. Jpn Circ J. 2001;13:516–20.
   Google Scholar
• Medsger T, Silman A, Steen V, Black C, Akesson A, Bacon P, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159–67.
   PubMed Web of Science ®Google Scholar
• Clements P, Lachenbruch L, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5.
   PubMed Web of Science ®Google Scholar
• Stemberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA. 1989;86:2374–8.
   PubMed Web of Science ®Google Scholar
• Del Ray A, Wolff C, Wildmann J, Randolf A, Hahnel A, Bese-dovsly HO, et al. Disrupted brain-immune system-joint commu-nication during experimental arthritis. Arthritis Rheum. 2008;58:3090–9.
   PubMed Web of Science ®Google Scholar
• Lechner 0, Hu Y, Jafarian-Tehrani M, Dietrich H, Schwarz S, Herold M, et al. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav Immunol. 1996;10:337–50.
   Google Scholar
• Eskandari F, Webster JI, Sternberg EM. Neural immune path-ways and their connection to inflammatory disease. Arthritis Res Ther. 2003;5:251–65.
   Google Scholar
• Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheu-matoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab. 2000;85:1461–6.
   PubMed Web of Science ®Google Scholar
• Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo M. Inadequately low serum levels steroid hormones in relation to interleukin-6 and necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 2002;46: 654–62.
   Google Scholar
• Straub RH, Harle P, Sarzi-Puttini P, Cutolo M. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of anti-inflammatory action. Arthritis Rheum. 2006;54:2039–46.
   Google Scholar
• Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Beaten D, Fleck M, et al. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum. 2008;58:976–84.
   PubMed Web of Science ®Google Scholar
• Bijlsma JW, Cutolo M, Straub RH, Masi AT. Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases. Rheum Dis Clin North Am. 2005;31:xiii-xvi.
   Google Scholar
• Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen U. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol. 2004;22:63–70.
   Google Scholar
• Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population val-ues? A cross-sectional study. Clin Rheumatol. 2000;19:195–9.
   PubMed Web of Science ®Google Scholar
• Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A, et al. Health-related quality of life in systemic scle-rosis as measured by the short form 36: relationship with clinical and biological markers. Arthritis Rheum. 2004;51: 475–81.
   Google Scholar
• Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M. Canadian Scleroderma research group. Clinical correlates of self-reported physical health status in systemic sclerosis. J Rheumatol. 2009;36:1226–9.
   Google Scholar
• Dekkers JC, Geenen R, Godaert GL, Glaudemans F, Lafeber F, Doornen LJ, et al. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol. 2001;28:1496–504.
   PubMed Web of Science ®Google Scholar
• Yoshino S, Mukai J, Kohda M. Effects of mirthful laughter on neuroendocrine and immune systems in patients with rheumatoid arthritis. J Rheumatol. 1996;23:793–4.
   Google Scholar
• Long K, Lubeck D, Kraines R, Seleznick M, Holman H. Out-comes of self-help education for patients with arthritis. Arthritis Rheum. 1985;28:680–5.
   PubMed Web of Science ®Google Scholar
• Long K, Holman H. Self-management education: history, defini-tion, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.
   PubMed Web of Science ®Google Scholar
• Rhee SH, Parker JC, Smarr KL, Petroski GF, Johnson JG, Hewett JE, et al. Stress management in rheumatoid arthritis: what is the underlying mechanism? Arthritis Care Res. 2000;13:435–42.
   Google Scholar
• Kate L, David S, Ritter P, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4:256–62.
   PubMedGoogle Scholar
• Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama 0, Koarada S, et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol. 2003;30:1782–987.
   Google Scholar